Mei-Li Wu

Title: Innovations of Mei-Li Wu in Immunology

Introduction

Mei-Li Wu is a prominent inventor based in Neipu, Taiwan. She has made significant contributions to the field of immunology, particularly in the development of vaccines and immune response evaluation methods. With a total of 5 patents, her work has the potential to impact veterinary medicine and beyond.

Latest Patents

One of her latest patents is focused on a recombinant antigen and a method of making the same, specifically targeting the porcine reproductive and respiratory syndrome virus (PRRSV). This invention includes an isolated polynucleotide that encodes a chimeric protein of PRRSV dual structural proteins and T-cell epitope. The recombinant protein expressed by this polynucleotide can facilitate mass production and purification, making it a valuable asset for vaccine development. Another notable patent involves an in vitro immune synapse system and a method for evaluating immune responses. This system allows for the assessment of immunogenicity and immunostimulatory properties of test samples, potentially reducing the need for animal experimentation.

Career Highlights

Mei-Li Wu is affiliated with the National Pingtung University of Science and Technology, where she continues her research and innovation in immunology. Her work is characterized by a strong focus on developing solutions that enhance immune responses in pigs, which is crucial for veterinary health.

Collaborations

She collaborates with notable colleagues such as Hso-Chi Chaung and Wen-Bin Chung, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Mei-Li Wu's contributions to immunology through her patents and research are paving the way for advancements in vaccine development and immune response evaluation. Her work exemplifies the impact of innovative thinking in addressing health challenges in veterinary medicine.